China, Qinhuangdao
Xiaojun Cao
Stem cell therapy at Panacee International Hospital Qinhuangdao in China provides advanced immune modulation and regenerative treatments. The hospital uses specialized cell types, including Peripheral Blood Stem Cells (PBSC) and NK cell therapy, for targeted health improvements. As the first Sino-foreign joint venture hospital in Hebei, this facility combines international medical standards with specialized local care.
Advanced Cell Therapy Methods
The hospital focuses on high-quality cell treatments to address various health needs. Patients can receive several types of advanced therapies:
- Peripheral Blood Stem Cell (PBSC) therapy for systemic regeneration.
- NK Cell Therapy to help the immune system fight diseases.
- Tumor immunotherapy for specialized cancer care support.
- Precision medicine to tailor treatments to each patient's genetic profile.
Quality and Safety Standards
Safety is a priority at this facility through strict cell processing protocols. All cells used in treatment are processed in GMP-certified laboratories. This certification helps make sure the cells are pure and safe for medical use. The hospital operates 12 specialized departments and maintains 50 patient beds for comfortable stays.
International Medical Expertise
The hospital is part of the Panacee Medical Group from Thailand. This connection brings an international network of medical knowledge to the Qinhuangdao facility. Being a Sino-foreign joint venture allows the hospital to use global medical protocols while operating in China. The medical team follows these standards to provide precision medicine and immune-based therapies.
If you are looking for advanced cell-based treatments in China, you can leave a request on Bookimed to learn more about the process.